Engineering cell lines for production of
β
Kyle G. Grant; David M. Krisky; Mohammed M. Ataai; Joseph C. Glorioso III
π
Article
π
2009
π
John Wiley and Sons
π
English
β 467 KB
## Abstract Herpes simplex virus type 1 (HSVβ1) represents an attractive vehicle for a variety of gene therapy applications. To render this virus safe for clinical use, its cytotoxic genes must be removed without losing its ability to express transgenes efficiently. Our vectors are deleted for the